Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: Results from the American College of Cardiology's NCDR®

American Heart Journal

Volumn 161, Issue 5, 2011, Pages 864-870

  Kontos, Michael C ^a,e   Diercks, Debra B ^b   Ho, P Michael ^c   Wang, Tracy Y ^d   Chen, Anita Y ^d   Roe, Matthew T ^d  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e Second Floor ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CARDIOGENIC SHOCK; EARLY INTERVENTION; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 79955918283     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.01.006     Document Type: Article

References (24)

1. Yusuf S., Wittes J., and Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction JAMA 260 1988 2088 2093
2. First International Study of Infarct Survival Collaborative Group Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1 Lancet 2 1986 57 66
3. Metoprolol in acute myocardial infarction (MIAMI) The MIAMI Trial Research Group A randomised placebo-controlled international trial Eur Heart J 6 1985 199 226
4. Van De W.F., Janssens L., and Brzostek T. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy J Am Coll Cardiol 22 1993 407 416 (Pubitemid 23214552)
5. Roberts R., Rogers W.J., and Mueller H.S. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study Circulation 83 1991 422 437
6. Anderson J.L., Adams C.D., and Antman E.M. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 50 2007 e1 e157
7. Antman E.M., Hand M., and Armstrong P.W. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
8. Chen Z.M., Pan H.C., and Chen Y.P. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1622 1632
9. Kandzari D.E., Roe M.T., and Chen A.Y. Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes Am Heart J 149 2005 474 481 (Pubitemid 40585411)
10. Yan A.T., Jong P., and Yan R.T. Clinical trial-derived risk model may not generalize to real-world patients with acute coronary syndrome Am Heart J 148 2004 1020 1027 (Pubitemid 39646978)
11. Peterson E.D., Roe M.T., and Rumsfeld J.S. A call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction Circ Cardiovasc Qual Outcomes 2 2009 491 499
12. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized linear models Biometrika 73 1986 13 22
13. Yusuf S., Peto R., and Lewis J. Beta blockade during and after myocardial infarction: an overview of the randomized trials Prog Cardiovasc Dis 27 1985 335 371 (Pubitemid 15107153)
14. Freemantle N., Cleland J., and Young P. beta Blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737 (Pubitemid 29290470)
15. Al Reesi A., Al Zadjali N., and Perry J. Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis CJEM 10 2008 215 223
16. Miller C.D. How little we know: the search for a simple answer on acute beta-blocker use in the management of acute coronary syndrome Acad Emerg Med 17 2010 93 95
17. Boersma E., Pieper K.S., and Steyerberg E.W. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients Circ 101 2000 2557 2567 (Pubitemid 30350632)
18. Lee K.L., Woodlief L.H., and Topol E.J. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators Circulation 91 1995 1659 1668
19. G Wiviott S.D., Morrow D.A., and Frederick P.D. Application of the thrombolysis in myocardial infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction J Am Coll Cardiol 47 2006 1553 1558
20. Frishman W.H. Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts Circulation 67 1983 I11 I18
21. Lopez-Sendon J., Swedberg K., and McMurray J. Expert consensus document on beta-adrenergic receptor blockers Eur Heart J 25 2004 1341 1362
22. Murray D.P., Murray R.G., and Rafiqi E. Beta-adrenergic blockade in acute myocardial infarction: a haemodynamic and radionuclide study Eur Heart J 8 1987 845 854 (Pubitemid 17136028)
23. Krumholz H.M., Anderson J.L., and Bachelder B.L. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures J Am Coll Cardiol 52 2008 2046 2099
24. Van De W.F., Bax J., and Betriu A. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945